CLINICAL SUPPLY MANAGEMENT ARTICLES
At The Point Of Review: How Clinical Shipments Are Evaluated In Practice
At review, clinical shipments become a single consolidated record. Delays arise when relationships between product identity, classification, and documentation are unclear.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
This white paper provides a comprehensive overview of the current supply planning landscape, identifies gaps inhibiting supply professionals from optimizing their supply chain, and delves into solutions for driving efficiencies from a people, process and technology perspective.
-
Signant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.
-
A global pharma leader improved supply chain efficiency and compliance by digitalizing processes with Signant's SmartSignals Supplies, achieving better visibility, traceability, and reduced errors.
-
Explore the ways technology suppliers across the clinical trial space have begun investing in IRTs built around a microservices model capable of improving data access and visibility.
-
DtP trials are a win-win for patients and sponsors. The purpose of this white paper is to provide in-depth information on the various DtP approaches while offering insight into best practices when incorporating DtP into the protocol.
-
Drive excellence in clinical trials by utilizing forecasting to better plan clinical supply budgets and project timelines, and identify potential supply-related issues before they negatively impact a study.
-
Clinical trials can be very complex. Discover the need to connect planning and oversight from sourcing to shipping, along with mastering requirements such as cold chain, border slowdowns, and data privacy.